Veradigm Dedicated to Helping Combat COVID-19

AllscriptsAs a leading provider of data and technology solutions, Allscripts (NASDAQ: MDRX) business unit, Veradigm, is at the forefront of the fight to help providers and researchers, and the patients they serve. The company is committed to leveraging its technology to help providers identify patients at risk for the virus and ensure they have the information and tools needed to help them. In addition, Veradigm is a founding member of a consortium dedicated to providing the data necessary for advancing COVID research.

COVID-19 Research Database

Veradigm is a founding collaborator of a consortium of leading healthcare companies who announced the launch of the COVID-19 Research Database earlier this week. The COVID-19 Research Database is a repository of HIPAA-compliant, de-identified and limited patient-level data sets that are intended to be made available to public health and policy researchers pro-bono, enabling them to extract insights to help combat the COVID-19 pandemic. As a collaborator of the consortium, Veradigm has committed to provide de-identified EHR patient data for nearly 60 million U.S. patients with a recent encounter.

COVID-19 Clinical Workflow Initiatives

Among its early efforts to help physicians identify patients at risk, Veradigm implemented a reminder that appears during the EHR log in process reminding providers to ask patients about recent travel and potential exposure when they present symptoms associated with COVID-19. It also began alerting physicians when a diagnostic code they enter for a patient aligns with CDC clinical criteria for COVID-19. The alert is displayed prominently, signals to the physician that the diagnosis is associated with COVID-19 and provides a link to CDC guidelines.

Most recently, Veradigm began deploying free video-conferencing services to its EHR providers, enabling them to deliver services during the peak period of this crisis through telemedicine, and helping control further contamination. Over the past months, Veradigm has offered valuable patient engagement tools to its customers, such as HIPAA-compliant secure texting and broadcast messaging.

Other initiatives Veradigm has taken include:

  • Implementing COVID-19 questionnaires within the software that enable documentation of current symptoms, recent travel outside the country and more.
  • Establishing a connection to the CDC website from within several places in the provider workflow within the EHR.
  • Launching a Physician and Patient resource section within its website that includes information on preparedness, screening and testing, prevention and control, management and treatment and patient education.
  • Offering providers video chat services to support telehealth.
  • Providing ePrescribe software that is EHR agnostic and can be used by any practice even if they don’t use its EHR.
  • Implementing changes to development process, enabling Veradigm to be swifter in implementing new alerts, diagnostic codes and other related efforts into the workflow of its EHR.

Veradigm is also continuing its long-standing policy to offer its EHR services free of charge to the local Free Clinics who are at the front line of this pandemic.

"We, at Veradigm, pledge to do our utmost to maintain the highest levels of service, reliability, and insight for patients and the providers that serve them," said Veradigm CEO, Tom Langan. "Our solutions are an integral part of toolsets that medical professionals are using to care for their patients, whether in person or telehealth."

About Veradigm™

Veradigm is an integrated data systems and services company that combines data-driven clinical insights with actionable tools to help healthcare stakeholders improve the quality, efficiency, and value of healthcare delivery - including biopharma, health plans, healthcare providers, health technology partners, and most importantly, the patients they serve. We are dedicated to simplifying the complicated healthcare system with next-generation healthcare solutions. This is how we are transforming health, insightfully.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...